Search Results

There are 3678 results for: content related to: Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease

  1. You have free access to this content
    Neuromyelitis optica: clinical features, immunopathogenesis and treatment

    Clinical & Experimental Immunology

    Volume 176, Issue 2, May 2014, Pages: 149–164, S. Jarius, B. Wildemann and F. Paul

    Version of Record online : 9 APR 2014, DOI: 10.1111/cei.12271

  2. You have free access to this content
    Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease

    Clinical & Experimental Immunology

    Volume 177, Issue 3, September 2014, Pages: 611–617, A. Tosco, R. Auricchio, R. Aitoro, D. Ponticelli, M. Primario, E. Miele, V. Rotondi Aufiero, V. Discepolo, L. Greco, R. Troncone and M. Maglio

    Version of Record online : 24 JUL 2014, DOI: 10.1111/cei.12366

  3. You have free access to this content
    Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum

    Clinical & Experimental Immunology

    Volume 175, Issue 2, February 2014, Pages: 150–166, G. A. Ramirez, N. Maugeri, M. G. Sabbadini, P. Rovere-Querini and A. A. Manfredi

    Version of Record online : 3 JAN 2014, DOI: 10.1111/cei.12223

  4. You have free access to this content
    Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

    Clinical & Experimental Immunology

    Volume 186, Issue 2, November 2016, Pages: 115–133, F. M. Rasche, F. Keller, W. G. Rasche, S. Schiekofer, A. Boldt, U. Sack and J. Fahnert

    Version of Record online : 8 SEP 2016, DOI: 10.1111/cei.12823

  5. You have free access to this content
    Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins

    Clinical & Experimental Immunology

    Volume 184, Issue 3, June 2016, Pages: 265–283, L. Wagner, C. Klemann, M. Stephan and S. von Hörsten

    Version of Record online : 2 MAR 2016, DOI: 10.1111/cei.12757

  6. You have free access to this content
    Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system

    Clinical & Experimental Immunology

    Volume 176, Issue 2, May 2014, Pages: 135–148, A. Salmen, R. Gold and A. Chan

    Version of Record online : 9 APR 2014, DOI: 10.1111/cei.12258

  7. You have free access to this content
    Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system

    Clinical & Experimental Immunology

    Volume 185, Issue 1, July 2016, Pages: 1–21, C. Klemann, L. Wagner, M. Stephan and S. von Hörsten

    Version of Record online : 13 MAY 2016, DOI: 10.1111/cei.12781

  8. You have free access to this content
    Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 397–407, P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer and O. Stüve

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12206

  9. You have free access to this content
    Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time

    Clinical & Experimental Immunology

    Volume 171, Issue 1, January 2013, Pages: 100–106, K. Swallow, G. Wild, R. Sargur, D. S. Sanders, I. Aziz, A. D. Hopper and W. Egner

    Version of Record online : 3 DEC 2012, DOI: 10.1111/cei.12000

  10. You have free access to this content
    Kawasaki disease: a matter of innate immunity

    Clinical & Experimental Immunology

    Volume 186, Issue 2, November 2016, Pages: 134–143, T. Hara, Y. Nakashima, Y. Sakai, H. Nishio, Y. Motomura and S. Yamasaki

    Version of Record online : 3 AUG 2016, DOI: 10.1111/cei.12832

  11. You have free access to this content
    Ageing and inflammation in patients with HIV infection

    Clinical & Experimental Immunology

    Volume 187, Issue 1, January 2017, Pages: 44–52, M. Nasi, S. De Biasi, L. Gibellini, E. Bianchini, S. Pecorini, V. Bacca, G. Guaraldi, C. Mussini, M. Pinti and A. Cossarizza

    Version of Record online : 9 AUG 2016, DOI: 10.1111/cei.12814

  12. You have free access to this content
    Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus

    Clinical & Experimental Immunology

    Volume 171, Issue 2, February 2013, Pages: 135–146, A. E. Barcala Tabarrozzi, C. N. Castro, R. A. Dewey, M. C. Sogayar, L. Labriola and M. J. Perone

    Version of Record online : 3 JAN 2013, DOI: 10.1111/cei.12019

  13. You have free access to this content
    Immunology of IgG4-related disease

    Clinical & Experimental Immunology

    Volume 181, Issue 2, August 2015, Pages: 191–206, E. Della-Torre, M. Lanzillotta and C. Doglioni

    Version of Record online : 8 JUN 2015, DOI: 10.1111/cei.12641

  14. You have full text access to this OnlineOpen article
    Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

    Clinical & Experimental Immunology

    Volume 181, Issue 3, September 2015, Pages: 385–400, B. Rup, M. Pallardy, D. Sikkema, T. Albert, M. Allez, P. Broet, C. Carini, P. Creeke, J. Davidson, N. De Vries, D. Finco, A. Fogdell-Hahn, E. Havrdova, A. Hincelin-Mery, M. C. Holland, P. E. H. Jensen, E. C. Jury, H. Kirby, D. Kramer, S. Lacroix-Desmazes, J. Legrand, E. Maggi, B. Maillère, X. Mariette, C. Mauri, V. Mikol, D. Mulleman, J. Oldenburg, G. Paintaud, C. R. Pedersen, N. Ruperto, R. Seitz, S. Spindeldreher, F. Deisenhammer and on behalf of the ABIRISK Consortium

    Version of Record online : 2 JUL 2015, DOI: 10.1111/cei.12652

  15. You have free access to this content
    Permissive and protective roles for neutrophils in leishmaniasis

    Clinical & Experimental Immunology

    Volume 182, Issue 2, November 2015, Pages: 109–118, E. D. Carlsen, Y. Liang, T. R. Shelite, D. H. Walker, P. C. Melby and L. Soong

    Version of Record online : 28 AUG 2015, DOI: 10.1111/cei.12674

  16. You have free access to this content
    Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

    Clinical & Experimental Immunology

    Volume 182, Issue 1, October 2015, Pages: 35–44, P. Ruscitti, P. Cipriani, P. Di Benedetto, V. Liakouli, O. Berardicurti, F. Carubbi, F. Ciccia, S. Alvaro, G. Triolo and R. Giacomelli

    Version of Record online : 19 JUL 2015, DOI: 10.1111/cei.12667

  17. You have free access to this content
    Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice

    Clinical & Experimental Immunology

    Volume 179, Issue 3, March 2015, Pages: 398–413, J. Babad, G. Mukherjee, A. Follenzi, R. Ali, B. O. Roep, L. D. Shultz, P. Santamaria, O. O. Yang, H. Goldstein, D. L. Greiner and T. P. DiLorenzo

    Version of Record online : 16 FEB 2015, DOI: 10.1111/cei.12465

  18. You have free access to this content
    Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats

    Clinical & Experimental Immunology

    Volume 179, Issue 2, February 2015, Pages: 161–172, O. Guttman, B. M. Baranovski, R. Schuster, Z. Kaner, G. S. Freixo-Lima, N. Bahar, N. Kalay, M. I. Mizrahi, I. Brami, D. E. Ochayon and E. C. Lewis

    Version of Record online : 2 JAN 2015, DOI: 10.1111/cei.12476

  19. You have free access to this content
    High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated

    Clinical & Experimental Immunology

    Volume 176, Issue 2, May 2014, Pages: 190–198, L. Beltran, M. Koenig, W. Egner, M. Howard, A. Butt, M. R. Austin, D. Patel, R. R. Sanderson, S. Goubet, F. Saleh, J. Lavender, E. Stainer and M. D. Tarzi

    Version of Record online : 9 APR 2014, DOI: 10.1111/cei.12249

  20. You have free access to this content
    Monoclonal antibodies in treatment of multiple sclerosis

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 373–384, P. S. Rommer, A. Dudesek, O. Stüve and U.K. Zettl

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12197